Cognitive-, neurodevelopment and long-term health follow-up of children born after preterm prelabor rupture of membranes.

Completed

• Conditions: ange termijn ontwikkeling; Preterm prelabor rupture of membranes and long-term cognitive- en neurodevelopment; 10010273

• Registration Number: NL-OMON47933
• Lead Sponsor: Academisch Medisch Centrum

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 28 February 2024

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 719

Inclusion Criteria

Singletons born to women who participated in the PPROMEXIL or PPROMEXIL-II trial (PPROMEXIL trial registered as ISRCTN05689407, PPROMEXIL-II approved by the Medical Ethics Committee of the Maastricht University Medical Center as an amendment of the PPROMEXIL trial: MEC 05-240).

Exclusion Criteria

None. This is a follow-up study, all singletons included in the PPROMEXIL or PPROMEXIL-II trial can participate.

Study & Design

• Study Type: Observational non invasive
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>Primary Objective: Child*s cognitive development. </p><br>

Secondary Outcome Measures

Name	Time	Method
<p>Secondary outcome: Child*s motor-, academic-, and behavioural development.<br /><br>Child*s general health (diseases, hospital admissions), child*s growth; as<br /><br>measured by length, weight, body composition, head circumference, blood<br /><br>pressure and child*s pulmonary function and respiratory problems. </p><br>